Filing Details
- Accession Number:
- 0001209191-15-010443
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-02-06 17:41:18
- Reporting Period:
- 2015-02-05
- Filing Date:
- 2015-02-06
- Accepted Time:
- 2015-02-06 17:41:18
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 875320 | Vertex Pharmaceuticals Inc / Ma | VRTX | Pharmaceutical Preparations (2834) | 043039129 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1446372 | M Paul Silva | C/O Vertex Pharmaceuticals Incorporated 50 Northern Avenue Boston MA 02210 | Svp & Corp Controller | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2015-02-05 | 1,688 | $45.11 | 25,750 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2015-02-05 | 400 | $108.81 | 25,350 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2015-02-05 | 900 | $109.74 | 24,450 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2015-02-05 | 388 | $110.76 | 24,062 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) | Disposition | 2015-02-05 | 1,688 | $0.00 | 1,688 | $45.11 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 13,500 | 2023-02-04 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 169 | Indirect | 401(k) |
Footnotes
- Transaction made pursuant to Mr. Silva's company approved trading plan under Rule 10b5-1.
- Open market sales reported on this line occurred at a weighted average price of $108.81 (range $108.27 to $109.10).
- Mr. Silva undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
- Open market sales reported on this line occurred at a weighted average price of $109.74 (range $109.45 to $110.13).
- Open market sales reported on this line occurred at a weighted average price of $110.76 (range $110.50 to $111.03).
- The option vests in 16 quarterly installments from 02/05/2013.
Billionaire Hedge Funds
